Presented by: Professor David Kaye, NHMRC Senior Principal Research Fellow
Director of Department of Cardiology, Alfred Hospital, Melbourne
Head of Heart Failure Research Division, Baker Heart and Diabetes Institute
Professor Kaye is recognised internationally for his work on the pathophysiology of heart failure. His studies have identified a range of the fundamental mechanisms that contribute to the progressive nature of heart failure. He has published over 340 research articles, his H index is 77, with over 23,000 citations.
Professor Kaye holds numerous research grants including an NHMRC Program Grant (as leader), NHMRC Centre of Research Excellence Grant and an NHMRC Development Grant.
Prof Kaye’s research has also created a substantial portfolio of intellectual property related to the invention of novel medical devices. These have been the basis for the formation of three start-up companies, including Osprey Medical which was successfully listed on the ASX. All companies have advanced active clinical trial programs.
Prof Kaye is the recipient of the Eric Susman and RT Hall Prizes for research excellence from the College of Physicians and Cardiac Society. He was awarded the 2012 Eureka Prize for Medical Research Translation.
Most significant clinical trial
A novel formulation of a drug used to treat advanced heart failure, now tested in over 40 patients with severe symptoms.
About Research Seminar Series
UQ School of Biomedical Sciences Research Seminar Series
The School of Biomedical Sciences (SBMS) Research Seminar Series presents seminars by international and national researchers, local researchers, and postdocs.
Unless otherwise indicated, seminars are held 3.00 PM AEST every second Friday 01-E109 - Forgan Smith Building, Learning Theatre.